These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 15218223

  • 1. Contribution of exotoxin A of Pseudomonas aeruginosa in acute and chronic experimental renal infection.
    Sharma S, Kaur R, Yadav V, Harjai K, Joshi K.
    Jpn J Infect Dis; 2004 Jun; 57(3):119-20. PubMed ID: 15218223
    [Abstract] [Full Text] [Related]

  • 2. The contribution of diffusible toxins of Pseudomonas aeruginosa to the pathogenesis of experimental pyelonephritis.
    Al-Ssum RM, Harris DM.
    J Infect; 1982 Jan; 4(1):49-55. PubMed ID: 6821099
    [No Abstract] [Full Text] [Related]

  • 3. Role of exotoxin A and elastase in the pathogenicity of Pseudomonas aeruginosa strain PAO experimental mouse burn infection.
    Wretlind B, Björklind A, Pavlovskis OR.
    Microb Pathog; 1987 Jun; 2(6):397-404. PubMed ID: 3148812
    [Abstract] [Full Text] [Related]

  • 4. The role of proteases and exotoxin A in the pathogenicity of Pseudomonas aeruginosa infections.
    Wretlind B, Pavlovskis OR.
    Scand J Infect Dis Suppl; 1981 Jun; 29():13-9. PubMed ID: 6797058
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of Pseudomonas aeruginosa exotoxin A and elastase as virulence factors in acute lung infection.
    Blackwood LL, Stone RM, Iglewski BH, Pennington JE.
    Infect Immun; 1983 Jan; 39(1):198-201. PubMed ID: 6401692
    [Abstract] [Full Text] [Related]

  • 6. Pseudomonas aeruginosa cystic fibrosis clinical isolates produce exotoxin A with altered ADP-ribosyltransferase activity and cytotoxicity.
    Gallant CV, Raivio TL, Olson JC, Woods DE, Storey DG.
    Microbiology (Reading); 2000 Aug; 146 ( Pt 8)():1891-1899. PubMed ID: 10931893
    [Abstract] [Full Text] [Related]

  • 7. [Significance of Pseudomonas aeruginosa virulence factors for acute and chronic Pseudomonas aeruginosa infections].
    Döring G.
    Infection; 1987 Aug; 15 Suppl 2():S38-41. PubMed ID: 3112018
    [Abstract] [Full Text] [Related]

  • 8. Determination of the amino acid change responsible for the nontoxic, cross-reactive exotoxin A protein (CRM 66) of Pseudomonas aeruginosa PAO-PR1.
    Wick MJ, Iglewski BH.
    J Bacteriol; 1988 Nov; 170(11):5385-8. PubMed ID: 3141388
    [Abstract] [Full Text] [Related]

  • 9. [Significance of Pseudomonas aeruginosa virulence factors in acute and chronic Pseudomonas aeruginosa infections].
    Döring G.
    Infection; 1987 Nov; 15(1):47-50. PubMed ID: 3106228
    [Abstract] [Full Text] [Related]

  • 10. Hypoxia Reduces the Pathogenicity of Pseudomonas aeruginosa by Decreasing the Expression of Multiple Virulence Factors.
    Schaible B, Rodriguez J, Garcia A, von Kriegsheim A, McClean S, Hickey C, Keogh CE, Brown E, Schaffer K, Broquet A, Taylor CT.
    J Infect Dis; 2017 May 01; 215(9):1459-1467. PubMed ID: 28368464
    [Abstract] [Full Text] [Related]

  • 11. The contribution of exoproducts to virulence of Pseudomonas aeruginosa.
    Nicas TI, Iglewski BH.
    Can J Microbiol; 1985 Apr 01; 31(4):387-92. PubMed ID: 2988728
    [Abstract] [Full Text] [Related]

  • 12. Role of exotoxin A in inducing severe Pseudomonas aeruginosa infections in mice.
    Miyazaki S, Matsumoto T, Tateda K, Ohno A, Yamaguchi K.
    J Med Microbiol; 1995 Sep 01; 43(3):169-75. PubMed ID: 7650723
    [Abstract] [Full Text] [Related]

  • 13. Pseudomonas aeruginosa exotoxin A antibodies in rapidly deteriorating chronic leg ulcers.
    Danielsen L, Westh H, Balselv E, Rosdahl VT, Döring G.
    Lancet; 1996 Jan 27; 347(8996):265. PubMed ID: 8551911
    [No Abstract] [Full Text] [Related]

  • 14. Pseudomonas aeruginosa exotoxin A and keratitis in mice.
    Pillar CM, Hobden JA.
    Invest Ophthalmol Vis Sci; 2002 May 27; 43(5):1437-44. PubMed ID: 11980858
    [Abstract] [Full Text] [Related]

  • 15. Pseudomonas keratitis. The role of an uncharacterized exoprotein, protease IV, in corneal virulence.
    O'Callaghan RJ, Engel LS, Hobden JA, Callegan MC, Green LC, Hill JM.
    Invest Ophthalmol Vis Sci; 1996 Mar 27; 37(4):534-43. PubMed ID: 8595953
    [Abstract] [Full Text] [Related]

  • 16. Preparation of recombinant atoxic form of exotoxin A from Pseudomonas aeruginosa.
    Kaloshin AA, Isakov MA, Mikhailova NA, Vertiev JV.
    Bull Exp Biol Med; 2013 Jan 27; 154(3):346-50. PubMed ID: 23484197
    [Abstract] [Full Text] [Related]

  • 17. Recombinant DNA approaches to the study of the regulation of virulence factors and epidemiology of Pseudomonas aeruginosa.
    Vasil ML, Ogle JW, Grant CC, Vasil AI.
    Antibiot Chemother (1971); 1987 Jan 27; 39():264-78. PubMed ID: 3118789
    [No Abstract] [Full Text] [Related]

  • 18. Biochemical and genetic aspects of Pseudomonas aeruginosa virulence.
    Lory S, Tai PC.
    Curr Top Microbiol Immunol; 1985 Jan 27; 118():53-69. PubMed ID: 2414071
    [No Abstract] [Full Text] [Related]

  • 19. Role of Pseudomonas aeruginosa extracellular enzymes in lung disease.
    Woods DE, Sokol PA.
    Clin Invest Med; 1986 Jan 27; 9(2):108-12. PubMed ID: 3089661
    [Abstract] [Full Text] [Related]

  • 20. Protective effect of DNA vaccine encoding pseudomonas exotoxin A and PcrV against acute pulmonary P. aeruginosa Infection.
    Jiang M, Yao J, Feng G.
    PLoS One; 2014 Jan 27; 9(5):e96609. PubMed ID: 24788626
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.